Trials / Withdrawn
WithdrawnNCT02674113
Regional Anesthesia in Hip Arthroscopy
Use of Regional Anesthesia in Hip Arthroscopy
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Missouri-Columbia · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research is to determine differences in outcomes in patients who receive regional anesthesia (a fascia iliaca block) versus placebo prior to undergoing hip arthroscopy with labral repair and/or debridement and osteoplasty for hip impingement.
Detailed description
Methods: After informed consent is obtained at a routine/pre-surgical clinic visit, all patients who meet eligibility criteria will undergo randomization into one of two groups. These groups are 1) to receive regional anesthesia (a single shot fascia iliaca block using bupivacaine) prior to hip arthroscopy, or 2) undergo a subcutaneous injection procedure using a normal saline placebo (0.9% sodium chloride in water) instead of bupivacaine. Intra-operatively, both groups will receive general anesthesia and local anesthesia (lidocaine and bupivacaine in the peripheral compartment).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | regional anesthesia bupivacaine | a single shot fascia iliaca block using bupivacaine prior to hip arthroscopy |
| DRUG | regional anesthesia placebo | subcutaneous injection procedure using a normal saline placebo (0.9% sodium chloride in water) |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2016-02-04
- Last updated
- 2017-02-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02674113. Inclusion in this directory is not an endorsement.